Martin M. Goldwyn is Director at HI TECH PHARMACAL CO INC (HITK). They have made 12 open-market trades across 1 company since 2006, most recently 2013-10-04.
CIK 0001186837
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HITK | 1,500 | — |
Shares reported on the most recent Form 4, priced at the 2013-10-08 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HITK | SELL | 2013-10-04 | 2013-10-08 | $43.10 | $65K | N/A | N/A | N/A |
| HITK | SELL | 2013-09-27 | 2013-10-01 | $43.10 | $129K | N/A | N/A | N/A |
| HITK | SELL | 2012-07-16 | 2012-07-17 | $31.40 | $200K | N/A | N/A | N/A |
| HITK | SELL | 2010-10-06 | 2010-10-07 | $21.22 | $21K | N/A | N/A | N/A |
| HITK | SELL | 2010-09-20 | 2010-09-20 | $20.84 | $21K | N/A | N/A | N/A |
| HITK | SELL | 2010-09-13 | 2010-09-15 | $20.22 | $40K | N/A | N/A | N/A |
| HITK | SELL | 2010-07-16 | 2010-07-20 | $20.46 | $61K | N/A | N/A | N/A |
| HITK | SELL | 2010-04-07 | 2010-04-09 | $22.61 | $62K | N/A | N/A | N/A |
| HITK | SELL | 2009-09-30 | 2009-10-01 | $22.11 | $22K | N/A | N/A | N/A |
| HITK | SELL | 2009-09-11 | 2009-09-15 | $21.17 | $144K | N/A | N/A | N/A |
| HITK | SELL | 2006-03-15 | 2006-03-17 | $27.25 | $48K | N/A | N/A | N/A |
| HITK | SELL | 2006-01-05 | 2006-01-09 | $44.32 | $55K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.